| scholarly article | Q13442814 |
| P2093 | author name string | Harry van Goor | |
| Joseph V Bonventre | |||
| Rudolf A de Boer | |||
| Gerjan Navis | |||
| Vishal S Vaidya | |||
| Andrea B Kramer | |||
| Mirjan M van Timmeren | |||
| Theo A Schuurs | |||
| Martin H de Borst | |||
| Mario B A van Dalen | |||
| P2860 | cites work | Cell-type-specific activation of mitogen-activated protein kinases in PAN-induced progressive renal disease in rats | Q45047292 |
| Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. | Q46713499 | ||
| SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung | Q46903300 | ||
| Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury | Q48039370 | ||
| Kidney injury molecule-1 expression in murine polycystic kidney disease. | Q53663851 | ||
| Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection. | Q53864061 | ||
| Tubular kidney injury molecule-1 in protein-overload nephropathy | Q28572259 | ||
| Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma | Q34195728 | ||
| Intrarenal angiotensin II and hypertension | Q35087015 | ||
| The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease | Q36335340 | ||
| Tubulointerstitial damage and progression of renal failure | Q36335362 | ||
| Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. | Q41078608 | ||
| Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. | Q44394484 | ||
| Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury | Q44643853 | ||
| Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats | Q44703364 | ||
| Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. | Q45025680 | ||
| P433 | issue | 1 | |
| P921 | main subject | kidney disease | Q1054718 |
| homozygosity | Q114049690 | ||
| P304 | page(s) | F313-20 | |
| P577 | publication date | 2006-08-08 | |
| P1433 | published in | American Journal of Physiology - Renal Physiology | Q2610177 |
| P1476 | title | Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. | |
| P478 | volume | 292 |
| Q37106622 | Aldosterone induces NRK-52E cell apoptosis in acute kidney injury via rno-miR-203 hypermethylation and Kim-1 upregulation |
| Q42043023 | Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin |
| Q36677752 | Can we target tubular damage to prevent renal function decline in diabetes? |
| Q36861560 | Cell therapy with human renal cell cultures containing erythropoietin-positive cells improves chronic kidney injury |
| Q37348057 | Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium |
| Q37073947 | Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats |
| Q37367978 | Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters |
| Q36877109 | Differential effects of sex steroids in young and aged female mRen2.Lewis rats: a model of estrogen and salt-sensitive hypertension |
| Q57938924 | Early biomarkers of renal injury and protective effect of erythropoietin on kidneys of asphyxiated newborn rats |
| Q35819489 | Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial |
| Q34803229 | Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy |
| Q27320627 | Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease |
| Q34670737 | Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy |
| Q35203400 | Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy. |
| Q45236430 | High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. |
| Q37349333 | High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients |
| Q42557196 | Immunolocalization of Kim-1, RPA-1, and RPA-2 in kidney of gentamicin-, mercury-, or chromium-treated rats: relationship to renal distributions of iNOS and nitrotyrosine |
| Q28570560 | Increased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restriction |
| Q28729196 | Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis |
| Q54066193 | Is urinary kidney injury molecule-1 a noninvasive marker for renal scarring in children with vesicoureteral reflux? |
| Q45833993 | KIM-1 expression predicts renal outcomes in IgA nephropathy. |
| Q38861649 | Kidney Injury Molecule-1 Is Specifically Expressed in Cystically-Transformed Proximal Tubules of the PKD/Mhm (cy/+) Rat Model of Polycystic Kidney Disease |
| Q37744081 | Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury |
| Q34042098 | Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury |
| Q37355170 | Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity |
| Q38054004 | Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells? |
| Q50069117 | Long-Term Effects of Neonatal Treatment With Dexamethasone, l-Carnitine, and Combinations Thereof in Rats |
| Q37052029 | Mammalian Target of Rapamycin Mediates Kidney Injury Molecule 1-Dependent Tubule Injury in a Surrogate Model. |
| Q84474026 | Novel biomarkers of acute kidney toxicity |
| Q46055734 | Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney |
| Q51746247 | Ovariectomy is protective against renal injury in the high-salt-fed older mRen2. Lewis rat. |
| Q39960357 | Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. |
| Q94544722 | Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole |
| Q37190253 | Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time |
| Q28078020 | Stop chronic kidney disease progression: Time is approaching |
| Q28572929 | Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats |
| Q39391487 | Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury |
| Q33789814 | Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. |
Search more.